IL-33 induced Ag-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Immunology

• Publication date

  2008-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.181.11.8170PMID 18802081
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IL-33 reduces the development of atherosclerosis

  2008cited by this paper
• IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.

  2008cited by this paper
• Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system.

  2008cited by this paper
• IL-33, a Potent Inducer of Adaptive Immunity to Intestinal Nematodes1

  2008cited by this paper
• Cutting Edge: The ST2 Ligand IL-33 Potently Activates and Drives Maturation of Human Mast Cells1

  2007cited by this paper
• The dual inhibitor of lipoxygenase and cyclooxygenase ML3000 decreases the expression of CXCR3 ligands

  2007cited by this paper
• IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex

  2007cited by this paper
• Invariant NKT Cells Biased for IL-5 Production Act as Crucial Regulators of Inflammation1

  2007cited by this paper
• IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells

  2007cited by this paper
• T1/ST2 expression on Th2 cells negatively regulates allergic pulmonary inflammation

  2007cited by this paper
• IL‐33 is a chemoattractant for human Th2 cells

  2007cited by this paper
• IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

  2007cited by this paper
• IL-33 can promote survival, adhesion and cytokine production in human mast cells

  2007cited by this paper
• Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway Inflammation*

  2007cited by this paper
• Asthma: defining of the persistent adult phenotypes.

  2006cited by this paper
• Expression of IL-4 receptor on non-bone marrow-derived cells is necessary for the timely elimination of Strongyloides venezuelensis in mice, but not for intestinal IL-4 production.

  2006cited by this paper
• Glucocorticoid‐induced TNFR family‐related protein (GITR) activation exacerbates murine asthma and collagen‐induced arthritis

  2005cited by this paper
• Independent roles for IL-2 and GATA-3 in stimulating naive CD4+ T cells to generate a Th2-inducing cytokine environment

  2005cited by this paper
• IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.

  2005cited by this paper
• Functional plasticity of human respiratory tract dendritic cells: GM-CSF enhances T(H)2 development.

  2005cited by this paper
• TLR2 Agonist Ameliorates Established Allergic Airway Inflammation by Promoting Th1 Response and Not via Regulatory T Cells1

  2005cited by this paper
• Interleukin 1 plays a major role in the development of Th2‐mediated immunity

  2004cited by this paper
• ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance

  2004cited by this paper
• Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

  2004cited by this paper
• Induction of T helper type 1–like regulatory cells that express Foxp3 and protect against airway hyper-reactivity

  2004cited by this paper
• Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung

  2004cited by this paper
• Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway

  2003cited by this paper
• IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo.

  2001cited by this paper
• Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4.

  2000cited by this paper
• IL‐18 induces the differentiation of Th1 or Th2 cells depending upon cytokine milieu and genetic background

  2000cited by this paper
• T1/St2-Deficient Mice Demonstrate the Importance of T1/St2 in Developing Primary T Helper Cell Type 2 Responses

  2000cited by this paper
• T1‐deficient and T1‐Fc‐transgenic mice develop a normal protective Th2‐type immune response following infection with Nippostrongylus brasiliensis

  2000cited by this paper
• A novel transcription factor, T-bet, directs Th1 lineage commitment.

  2000cited by this paper
• The Absence of Interleukin 1 Receptor–Related T1/St2 Does Not Affect T Helper Cell Type 2 Development and Its Effector Function

  1999cited by this paper
• Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling.

  1999cited by this paper
• Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling.

  1999cited by this paper
• Simultaneous Disruption of Interleukin (IL)-4 and IL-13 Defines Individual Roles in T Helper Cell Type 2–mediated Responses

  1999cited by this paper
• Crucial Role of the Interleukin 1 Receptor Family Member T1/St2 in T Helper Cell Type 2–Mediated Lung Mucosal Immune Responses

  1999cited by this paper
• IL-13 in allergy: home at last.

  1999cited by this paper
• Selective Expression of a Stable Cell Surface Molecule on Type 2 but Not Type 1 Helper T Cells

  1998cited by this paper
• Interleukin-13: central mediator of allergic asthma.

  1998cited by this paper
• Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function.

  1998cited by this paper
• T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function.

  1998cited by this paper
• Requirement for IL-13 independently of IL-4 in experimental asthma.

  1998cited by this paper
• IL-5-dependent immunity to microfilariae is independent of IL-4 in a mouse model of onchocerciasis.

  1998cited by this paper
• The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells.

  1997cited by this paper
• Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins.

  1997cited by this paper
• Interleukin (IL)-6 Directs the Differentiation of IL-4–producing CD4+ T Cells

  1997cited by this paper
• Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted State6 gene

  1996cited by this paper
• Essential role of Stat6 in IL-4 signalling

  1996cited by this paper
• Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model

  1996cited by this paper
• Susceptibility to Leishmania major Infection in Interleukin-4-Deficient Mice

  1996cited by this paper
• Schistosoma mansoni in IL-4-deficient mice.

  1996cited by this paper
• The immune response to Plasmodium chabaudi malaria in interleukin‐4‐deficient mice

  1994cited by this paper
• Disruption of the murine IL-4 gene blocks Th2 cytokine responses

  1993cited by this paper
• Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

  1992cited by this paper
• TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

  1989cited by this paper

• Molecular requirements of pathogenic Th2 cell differentiation in allergic airway disease.

  2026cites this paper
• An Innovative Immunotoxin Design Against Allergy Based on the IL-33 Cytokine and the Ribotoxin α-Sarcin

  2025cites this paper
• Roles of glucagon-like peptide 1 receptor agonists in immune cell biology and autoimmune/autoinflammatory diseases

  2025cites this paper
• Unlocking IL-33: New Insights into Tumor Immunity

  2025cites this paper
• Airway epithelial cells as drivers of severe asthma pathogenesis.

  2025cites this paper
• Engineered Neuromedin U Promotes Type 2 Innate Immunity and Renoprotection in Acute Kidney Injury.

  2025cites this paper
• Interleukin-33 and Obesity-Related Inflammation and Cancer

  2024cites this paper
• Proteogenomic analysis integrated with electronic health records data reveals disease-associated variants in Black Americans

  2024cites this paper
• Selective production of IL-33-neutralizing autoantibody ameliorates asthma responses and severity.

  2024cites this paper
• Inflammatory cytokine signalling in vulvovaginal candidiasis: a hot mess driving immunopathology

  2024cites this paper
• The production, function, and clinical applications of IL-33 in type 2 inflammation-related respiratory diseases

  2024cites this paper
• House dust mite allergen Der f 2 drives IL-6 and GM–CSF expression in airway epithelial cells via p38 MAPK/NF-κB signaling

  2024cites this paper
• NRF2 is a spatiotemporal metabolic hub essential for the polyfunctionality of Th2 cells

  2024cites this paper
• Differential and cooperative effects of IL-25 and IL-33 on T helper cells contribute to cryptococcal virulence and brain infection

  2023cites this paper
• Role of IL-33-ST2 pathway in regulating inflammation: current evidence and future perspectives

  2023cites this paper
• Neuron-Glia Crosstalk: Investigating Immune-Cell Modulation in the CNP1 Null Mutant Mouse

  2023cites this paper
• High fat diet induced resistance to helminth infection via alternative induction of Type 2 immunity.

  2023cites this paper
• IL-33-induced neutrophilic inflammation and NETosis underlie rhinovirus-triggered exacerbations of asthma.

  2023cites this paper
• The role of interleukin-33 in organ fibrosis

  2022cites this paper
• Translating the biology of β common receptor-engaging cytokines into clinical medicine.

  2022cites this paper
• Dual Immune Regulatory Roles of Interleukin-33 in Pathological Conditions

  2022cites this paper
• Dual roles of interleukin-33 in cognitive function by regulating central nervous system inflammation

  2022cites this paper
• Rapamycin Dampens Inflammatory Properties of Bone Marrow ILC2s in IL-33-Induced Eosinophilic Airway Inflammation

  2022cites this paper
• IL-33/ST2 axis promotes remodeling of the extracellular matrix and drives protective microglial responses in the mouse model of perioperative neurocognitive disorders.

  2022cites this paper
• IL‐33/ST2 as a potential target for tumor immunotherapy

  2021cites this paper
• Reducing Lung ATP Levels and Alleviating Asthmatic Airway Inflammation through Adeno-Associated Viral Vector-Mediated CD39 Expression

  2021cites this paper
• The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier

  2021cites this paper
• Unravelling the therapeutic potential of IL-33 for atrophic AMD

  2021cites this paper
• 12/15-Lipoxygenase Regulates IL-33-Induced Eosinophilic Airway Inflammation in Mice

  2021cites this paper
• Mast cell phenotypic plasticity and their activity under the influence of cathelicidin-related antimicrobial peptide (CRAMP) and IL-33 alarmins.

  2021cites this paper
• Biologics in food allergy: up-to-date

  2021cites this paper
• Soluble ST2 levels for predicting the presence and severity of metabolic syndrome

  2021cites this paper
• Il4ra-independent vaginal eosinophil accumulation following helminth infection exacerbates epithelial ulcerative pathology of HSV-2 infection

  2021cites this paper
• Detrimental role of IL-33/ST2 pathway sustaining a chronic eosinophil-dependent Th2 inflammatory response, tissue damage and parasite burden during Toxocara canis infection in mice

  2021cites this paper
• IL‐37 regulates allergic inflammation by counterbalancing pro‐inflammatory IL‐1 and IL‐33

  2021cites this paper
• Cytokine Regulation and Function in T Cells.

  2021cites this paper
• Interplay Between the IL-33/ST2 Axis and Bone Marrow ILC2s in Protease Allergen-Induced IL-5-Dependent Eosinophilia

  2020cites this paper
• Altered behavior in mice overexpressing soluble ST2

  2020cites this paper
• House Dust Mite Induces Bone Marrow IL-33-Responsive ILC2s and TH Cells

  2020cites this paper
• Calcio-herbal formulation, Divya-Swasari-Ras, alleviates chronic inflammation and suppresses airway remodelling in mouse model of allergic asthma by modulating pro-inflammatory cytokine response.

  2020cites this paper
• Exophilin-5 regulates allergic airway inflammation by controlling IL-33-mediated Th2 responses.

  2020cites this paper
• Association between IL-33 Gene Polymorphism (Rs7044343) and Risk of Allergic Rhinitis

  2020cites this paper
• Dual immune functions of IL-33 in inflammatory bowel disease.

  2020cites this paper
• T reg cell–intrinsic requirements for ST2 signaling in health and neuroinflammation

  2020cites this paper
• Egg yolk augments type 2 immunity by activating innate cells

  2020cites this paper
• Allergic inflammation is initiated by IL-33–dependent crosstalk between mast cells and basophils

  2020cites this paper
• The role of innate immunity in asthma development and protection: Lessons from the environment

  2020cites this paper
• Th2 cells promote eosinophil‐independent pathology in a murine model of allergic bronchopulmonary aspergillosis

  2020cites this paper
• Endogenous IL-33 and Its Autoamplification of IL-33/ST2 Pathway Play an Important Role in Asthma

  2020cites this paper
• The Airway Epithelium—A Central Player in Asthma Pathogenesis

  2020cites this paper
• IL-33 Mediates Lung Inflammation by the IL-6-Type Cytokine Oncostatin M

  2020cites this paper
• Early Treatment of Interleukin-33 can Attenuate Lupus Development in Young NZB/W F1 Mice

  2020cites this paper
• Interleukin-33 Promotes Serotonin Release from Enterochromaffin Cells for Intestinal Homeostasis.

  2020cites this paper
• Protective Effects of Korean Herbal Remedy against Airway Inflammation in an Allergic Asthma by Suppressing Eosinophil Recruitment and Infiltration in Lung

  2020cites this paper
• Herbal decoction Divya-Swasari-Kwath attenuates airway inflammation and remodeling through Nrf-2 mediated antioxidant lung defence in mouse model of allergic asthma.

  2020cites this paper
• Anacardic acid induces IL-33 and promotes remyelination in CNS

  2020cites this paper
• CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in Mice

  2020cites this paper
• Nuocytes from mesenteric lymph node promote allergic responses in a mouse model

  2020cites this paper
• Alteration of the IL-33-sST2 pathway in hypertensive patients and a mouse model

  2019cites this paper
• Shaping the diversity of Th2 cell responses in epithelial tissues and its potential for allergy treatment

  2019cites this paper
• Advanced Molecular Knowledge of Therapeutic Drugs and Natural Products Focusing on Inflammatory Cytokines in Asthma

  2019cites this paper
• Contribution of tissue transglutaminase to the severity of hepatic fibrosis resulting from Schistosoma japonicum infection through the regulation of IL-33/ST2 expression

  2019cites this paper
• The role of the IL-33/ST2 axis in autoimmune disorders: Friend or foe?

  2019cites this paper
• Intervention of Orai1 Influences the Response of Nuocytes From Allergic Rhinitis Mice to IL-33

  2019cites this paper
• New Targeted Therapies for Uncontrolled Asthma.

  2019cites this paper
• Interleukin-33 and ST2 Signaling in Tumor Microenvironment

  2019cites this paper
• ST2/MyD88 Deficiency Protects Mice against Acute Graft-versus-Host Disease and Spares Regulatory T Cells

  2019cites this paper
• Transcription factor and cytokine regulation of eosinophil lineage commitment.

  2019cites this paper
• Interleukin‐33 activates and recruits natural killer cells to inhibit pulmonary metastatic cancer development

  2019cites this paper
• Proinflammatory Pathways in the Pathogenesis of Asthma.

  2019cites this paper
• Pleiotropic Effects of IL-33 on CD4+ T Cell Differentiation and Effector Functions

  2019cites this paper
• Interleukin-33 Promotes REG3γ Expression in Intestinal Epithelial Cells and Regulates Gut Microbiota

  2019cites this paper
• Interleukin (IL)-33 and the IL-1 Family of Cytokines-Regulators of Inflammation and Tissue Homeostasis.

  2019cites this paper
• Could interleukin-33 and its suppressor of tumorigenicity 2 (ST2) receptor have a role in cervical human papillomavirus (HPV) infections?

  2019cites this paper
• Targeted deletion of NFAT-Interacting-Protein-(NIP) 45 resolves experimental asthma by inhibiting Innate Lymphoid Cells group 2 (ILC2)

  2019cites this paper
• IL-33 at the Crossroads of Metabolic Disorders and Immunity

  2019cites this paper
• Role of IL-17 in asthma pathogenesis and its implications for the clinic

  2019cites this paper
• Damage-associated molecular patterns in trauma

  2019cites this paper
• Interleukin-33/ST2 Signaling Promotes Hepatocellular Carcinoma Cell Stemness Expansion Through Activating c-Jun N-terminal Kinase Pathway.

  2019cites this paper
• Elevated levels of interleukin‐33 are associated with allergic and eosinophilic asthma

  2019cites this paper
• Aspergillus fumigatus induction of IL‐33 expression in chronic rhinosinusitis is PAR2‐dependent

  2019cites this paper
• Interleukin‑33 expression in ovarian cancer and its possible suppression of peritoneal carcinomatosis.

  2019cites this paper
• Chinese medicine Yu-Ping-Feng-San attenuates allergic inflammation by regulating epithelial derived pro-allergic cytokines.

  2019cites this paper
• Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis

  2019cites this paper
• Pathogenicity of memory Th2 cells is linked to stage of allergic rhinitis

  2018cites this paper
• Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targets.

  2018cites this paper
• IL-33 Upregulates Cysteinyl Leukotriene Receptor Type 1 Expression in Human Peripheral Blood CD4+ T Lymphocytes

  2018cites this paper
• Pulmonary neuroendocrine cells amplify allergic asthma responses

  2018cites this paper
• Antialarmins for treatment of asthma: future perspectives

  2018cites this paper
• Differential Influence on Regulatory B Cells by TH2 Cytokines Affects Protection in Allergic Airway Disease

  2018cites this paper
• The PGI2 Analog Cicaprost Inhibits IL-33–Induced Th2 Responses, IL-2 Production, and CD25 Expression in Mouse CD4+ T Cells

  2018cites this paper
• RETRACTED ​ARTICLE: Interleukin-33 promotes helper T cell type-2/17 inflammation in children with allergic rhinitis

  2018cites this paper
• Evaluation of biomaterial scaffold delivery of IL-33 as a localized immunomodulatory agent to support cell transplantation in adipose tissue.

  2018cites this paper
• Toll-Interacting Protein, Tollip, Inhibits IL-13-Mediated Pulmonary Eosinophilic Inflammation in Mice

  2018cites this paper
• Glucagon‐like peptide 1 signaling inhibits allergen‐induced lung IL‐33 release and reduces group 2 innate lymphoid cell cytokine production in vivo

  2018cites this paper
• RAGE‐dependent VCAM‐1 expression in the lung endothelium mediates IL‐33‐induced allergic airway inflammation

  2018cites this paper
• ST2/MYD88 signaling is a therapeutic target alleviating murine acute graft-versus-host disease sparing T regulatory cell function

  2018cites this paper
• Interleukin-33 Protects Ischemic Brain Injury by Regulating Specific Microglial Activities.

  2018cites this paper
• IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis

  2018cites this paper
• Th2 axis‐related cytokines in patients with neuromyelitis optica spectrum disorders

  2018cites this paper